Your browser doesn't support javascript.
loading
Medication contaminants as a potential cause of anaphylaxis to vincristine.
Hill, David A; Leahy, Allison Barz; Sciasci, Joseph; O'Neill, Sean P; Reilly, Anne; Balamuth, Naomi; Seeholzer, Steven H; Spergel, Jonathan M; Brown-Whitehorn, Terri F.
Afiliação
  • Hill DA; Department of Pediatrics, Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Leahy AB; Institute for Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Sciasci J; Department of Pediatrics, Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • O'Neill SP; Department of Pharmacy, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Reilly A; Office of Safety and Medical Operations, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Balamuth N; Department of Pediatrics, Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Seeholzer SH; Department of Pediatrics, Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Spergel JM; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Brown-Whitehorn TF; Department of Pediatrics, Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Pediatr Blood Cancer ; 65(1)2018 Jan.
Article em En | MEDLINE | ID: mdl-28834048
ABSTRACT
Vincristine (VCR) is a vinca alkaloid and common chemotherapeutic that is used to treat multiple pediatric and adult malignancies. Despite its common use, cases of anaphylaxis to VCR are rare and typically isolated to a single individual. We report a series of eight patients with adverse reactions to VCR over the course of 11 months at a single institution, four of which progressed to anaphylaxis and one of which resulted in cardiac arrest. Mass spectrometry analysis of medication lots was performed to test for possible contaminant(s). Our findings highlight the risk of anaphylaxis during therapy with VCR.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vincristina / Contaminação de Medicamentos / Anafilaxia / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vincristina / Contaminação de Medicamentos / Anafilaxia / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article